PET/CT in paediatric malignancies - An update

PET/CT in paediatric malignancies - An update

Blog Article

18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a well-established imaging modality in adult oncological practice.Its role in childhood malignancies needs to be discussed as paediatric malignancies differ from adults in tumor subtypes and they have different tumor biology and FDG uptake patterns.This is also compounded by smaller body mass, dosimetric restrictions, and physiological factors that can affect the FDG uptake.

It calls for careful Suncatcher Ornament planning of the PET study, preparing the child, the parents, and expertise of nuclear physicians in reporting pediatric positron emission tomography/computed tomography (PET/CT) studies.In a broad perspective, FDG-PET/CT has been used in staging, assessment of therapy response, identifying Car Radio metastases and as a follow-up tool in a wide variety of pediatric malignancies.This review outlines the role of PET/CT in childhood malignancies other than hematological malignancies such as lymphoma and leukemia.